Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This is a phase II, multicenter, single-arm, open-label safety and efficacy study of
bavituximab in combination with carboplatin plus paclitaxel in patients with locally advanced
or metastatic breast cancer.